Profitability Ratios
| Ratio |
Value |
| GP Margin |
72.1% |
| EBIT Margin |
14.6% |
| EBITDA Margin |
26.7% |
| Operating Margin |
20.5% |
| Pretax Margin |
12.9% |
| Cont. Ops Margin |
10.7% |
| Net Margin |
16.7% |
| Bottom Line Margin |
16.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.09 |
| Quick Ratio |
0.73 |
| Solvency Ratio |
0.245 |
| Cash Ratio |
0.27 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.28 |
| Forward PEG |
0.28 |
| Price/Book |
1.41 |
| Price/Sales |
2.15 |
| Price/FCF |
9.92 |
| Price/Op Cash Flow |
8.30 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1603 |
| Debt/Equity |
0.2848 |
| Debt/Capital |
0.2217 |
| Long-Term Debt/Capital |
0.1664 |
| Financial Leverage |
1.78 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
5.83 |
| Operating Cash Flow Ratio |
0.428 |
| Operating Cash Flow/Sales |
26.0% |
| Free Cash Flow/Operating Cash Flow |
83.6% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.30 |
| Interest Coverage |
15.3307 |
| Short-Term Operating Cash Flow Coverage |
2.79 |
| Operating Cash Flow Coverage |
0.60 |
| Capital Expenditure Coverage |
6.10 |
| Dividend + Capital Expenditure Coverage |
1.65 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
68.9309% |
| Dividend Yield |
5.3498% |
| Dividend Yield % |
5.3498% |
| Dividend Per Share |
2.2065 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
19.14 |
| EPS |
3.201 |
| Debt/Share |
8.5853 |
| Cash/Share |
3.47 |
| Book Value/Share |
29.38 |
| Tangible BV/Share |
1.70 |
| Equity/Share |
29.24 |
| Operating Cash Flow/Share |
4.971 |
| Capital Expenditure/Share |
0.815 |
| FCF/Share |
4.156 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.298 |
| Earnings Before Tax/EBIT |
0.627 |
| Price/Fair Value |
1.41 |
| Debt/Market Cap |
0.1847 |
| Effective Tax Rate |
17.3% |
| Enterprise Value Multiple |
9.08 |
SNY - Sanofi